scorecardresearch
Add as a preferred source on Google
Sunday, November 30, 2025
TopicSerum Institute India

Topic: Serum Institute India

How Serum Institute, DNDi tie-up for affordable antibody will bolster global fight against dengue

There is no specific medicine for dengue yet. If ongoing Phase III trials yield positive results, an effective, affordable & specific antiviral would be available, 'ultimately saving more lives'. 

Karan Johar’s studio sells 50% stake worth 10 bn rupees to vaccine maker Adar Poonawalla

SII CEO will buy stake through his production company, Serene Productions -- another major investment outside pharma sector after picking up 20% of social media platform Wakau Interactive in 2021.

Serum Institute to double investment in Biocon’s unit to $300 million

Under new terms of the alliance, it would pump in $150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd, the company said.

Rising Covid cases in China concerning but India need not panic, says SII CEO Aadar Poonawalla

The Serum Institute CEO’s tweet came a day after the Health Ministry urged states to ramp up the genome sequencing of positive samples to keep track of newer Covid variants.

Covid on the wane, Serum Institute eyes November launch for India’s first cervical cancer shot

HPV responsible for 95% of all cervical cancer. National Technical Advisory Group on Immunisation recommended HPV vaccine's inclusion in India's Universal Immunisation Programme in 2017.

Serum Institute plans to launch Covid vaccine for children in next 6 months

Speaking at a conference Tuesday, Serum Institute of India's CEO Adar Poonawalla said the Covovax vaccine is under trial & would offer protection to children as young as 3 years.

Not in favour of mixing two Covid vaccines for better efficacy, says Cyrus Poonawalla

If cocktail vaccines are administered and if the result is not good, then SII may say that another vaccine was not good or vice versa, Poonawalla added.

DCGI grants permission to Serum Institute to manufacture Sputnik V in India

The permission has been granted for examination, test and analysis of the Sputnik vaccine at SII's licensed Hadapsar facility under certain conditions, official sources said.

Serum Institute says executive’s remarks on Covid vaccination drive is ‘not company’s view’

Suresh Jadav, executive director, Serum Institute, alleged Friday that the govt began vaccinating people without taking into account available stock of vaccines and WHO guidelines.

On Camera

There’s pollution, violence, volcanic ash on my screen. And yet an email is more stressful

Years are quietly being stripped off my lifespan, and somehow that doesn’t ruin my day. But getting scolded for one careless word in an email? That can send me spiralling.

Karnataka startups feel the chill as global funding winter sets in. Fintech emerges as sole bright spot

The state raises just $2.7 billion in first nine months of 2025 compared to $4.5 billion last year, with late-stage investments hit hardest.

What’s expected from Putin’s India visit in December—Defence Secretary explains

ThePrint had previously reported that India & Russia are talking about 5 more regiments of the S-400, but no contracts are to be signed during the Russian president's visit.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.